Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis-Reference-Cited by-同舟云学术

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

Published:2018-12-19 Issue:4 Volume:62 Page:655-664
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Perdigoto Ana Luisa, ,Preston-Hurlburt Paula,Clark Pamela,Long S. Alice,Linsley Peter S.,Harris Kristina M.,Gitelman Steven E.,Greenbaum Carla J.,Gottlieb Peter A.,Hagopian William,Woodwyk Alyssa,Dziura James,Herold Kevan C.

Funder

Juvenile Diabetes Research Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-018-4786-9/fulltext.html

Reference18 articles.

1. Herold KC, Vignali DA, Cooke A, Bluestone JA (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13(4):243–256. https://doi.org/10.1038/nri3422

2. Reed JC, Herold KC (2015) Thinking bedside at the bench: the NOD mouse model of T1DM. Nat Rev Endocrinol 11(5):308–314. https://doi.org/10.1038/nrendo.2014.236

3. Naushad N, Perdigoto AL, Rui J, Herold KC (2017) Have we pushed the needle for treatment of type 1 diabetes? Curr Opin Immunol 49:44–50. https://doi.org/10.1016/j.coi.2017.09.004

4. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361(22):2143–2152. https://doi.org/10.1056/NEJMoa0904452

5. Pescovitz MD, Greenbaum CJ, Bundy B et al (2014) B-lymphocyte depletion with rituximab and beta-cell function: two-year results. Diabetes Care 37(2):453–459. https://doi.org/10.2337/dc13-0626

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus;Clinical Diabetes and Endocrinology;2024-08-10

2. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis;World Journal of Diabetes;2024-07-15

3. Autoimmune Form des Typ-1-Diabetes mellitus: Mit Kombinationstherapie einer Heilung näher kommen;Deutsches Ärzteblatt Online;2024-06-28

4. Autologous hematopoietic stem cell transplantation as a method of immune prevention of type 1 diabetes mellitus: possibilities and prospects;Diabetes mellitus;2024-06-27

5. Alternative therapeutic strategies in diabetes management;World Journal of Diabetes;2024-06-15